Partial replicate pivotal study: why? [Design Issues]

posted by Helmut Homepage – Vienna, Austria, 2014-11-11 12:31 (4245 d 07:52 ago) – Posting: # 13857
Views: 5,643

Dear Jay,

❝ For highly variable drugs with intrasubject CV more than 30% we go for partial replicate, reference replicated study design.


Why the lousy TRR|RRT|RTR? Hint: Search the forum.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
396 visitors (0 registered, 396 guests [including 28 identified bots]).
Forum time: 21:24 CEST (Europe/Vienna)

Ignorance more frequently begets confidence
than does knowledge.    Charles Darwin

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5